ACTG

Acacia Research Corp. 10-Q Summary: Period Ended June 30, 2026

Business Context and Reporting Period

This is a Quarterly Report on Form 10-Q for Acacia Research Corporation (ACTG) for the period ended June 30, 2026. Acacia operates as a value-oriented acquirer and operator across four primary segments: Intellectual Property (IP) Operations, Industrial Operations (Printronix), Energy Operations (Benchmark Energy), and Manufacturing Operations (Deflecto). The company is an Accelerated Filer and a Smaller Reporting Company.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Volatility: Total revenue increased 124% year-over-year for the quarter ($114.6M vs. $51.2M) driven by a massive spike in IP Operations revenue ($60.9M vs. $0.3M). However, for the six-month period, total revenue decreased 4% ($168.8M vs. $175.7M) due to lower IP and Manufacturing revenues.
• Significant Impairment: The company recognized a $30.9 million impairment charge related to its equity method investment in MalinJ1 (part of the Life Sciences Portfolio), reducing the carrying amount to zero. This charge was the primary driver of the net loss for the six-month period.
• Segment Performance:
  • IP Operations: Revenue surged in Q2 due to executed paid-up license agreements, but costs rose significantly due to contingent legal fees and inventor royalties.
  • Energy Operations: Revenue increased 34% in Q2 and 17% for the six months, driven by higher oil production volumes and realized prices.
  • Manufacturing & Industrial: Both segments saw revenue declines year-over-year due to lower unit sales and demand headwinds.
• Working Capital: Accounts receivable increased significantly to $86.7 million (from $26.2 million at year-end), impacting operating cash flow.

Guidance, Outlook, and Risks

• Outlook: Management maintains a focus on acquiring businesses with stable cash flow and the ability to scale. The company intends to finance future acquisitions through cash on hand or debt/equity financing.
• Key Risks:
  • IP Litigation: Fluctuations in patent-related legal expenses and the uncertainty of litigation outcomes remain material risks.
  • Commodity Prices: Energy operations are exposed to oil and natural gas price volatility, though the company utilizes hedging strategies.
  • Investment Impairments: The recent $30.9M write-down highlights the risk associated with the company's equity investment portfolio.
  • Trade Policy: Tariffs and trade regulations continue to pose challenges for the Manufacturing and Industrial segments.
• Unusual Items: The $30.9M impairment of the MalinJ1 investment is a non-cash, non-recurring item that significantly distorted net income for the period.

Investor Verification Checklist

• Impairment Details: Verify the specific reasons for the MalinJ1 impairment and assess if other equity method investments face similar valuation risks.
• IP Receivables: Review the aging of the $86.7 million accounts receivable balance, particularly within the IP segment, to assess collection risk given the timing of license fee payments.
• Debt Covenants: Confirm continued compliance with financial covenants for the Benchmark Revolving Credit Facility ($59.5M outstanding) and Deflecto Facility ($30.9M outstanding).
• Legal Contingencies: Monitor the status of pending patent litigation and the associated contingent legal fee liabilities, which increased to $52.0 million on the balance sheet.
• Cash Flow Sustainability: Analyze the divergence between operating income and operating cash flow ($7.3M for six months) to understand the impact of working capital changes on liquidity.